Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Eleonóra Klímová"'
Autor:
Ema Kantorová, Marianna Vítková, Martina Martiníková, Andrea Cimprichová, Miriam Fedicˇová, Slavomíra Kovácˇová, Miroslav Mako, Juraj Cisár, Viera Hancˇinová, Jarmila Szilasiová, Peter Koleda, Jana RoháIˇová, Jana Polóniová, Martin Karlík, Darina Slezáková, Eleonóra Klímová, Matúš Maciak, Egon Kurcˇa, Petra Hnilicová
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Background: Alemtuzumab (ALEM) is a humanised monoclonal antibody that depletes circulating lymphocytes by selectively targeting CD52, which is expressed in high levels on T- and B-lymphocytes. This depletion is followed by lymphocyte repopulation an
Externí odkaz:
https://doaj.org/article/2a1d7ef584194f8c9b83c37de0ea4bad
Autor:
Thomas Berger, Monika Adamczyk-Sowa, Tünde Csépány, Franz Fazekas, Tanja Hojs Fabjan, Dana Horáková, Alenka Horvat Ledinek, Zsolt Illes, Gisela Kobelt, Saša Šega Jazbec, Eleonóra Klímová, Fritz Leutmezer, Konrad Rejdak, Csilla Rozsa, Johann Sellner, Krzysztof Selmaj, Pavel Štouracˇ, Jarmila Szilasiová, Peter Turcˇáni, Marta Vachová, Manuela Vanecková, László Vécsei, Eva Kubala Havrdová
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 13 (2020)
At two meetings of a Central European board of multiple sclerosis (MS) experts in 2018 and 2019 factors influencing daily treatment choices in MS, especially practice guidelines, biomarkers and burden of disease, were discussed. The heterogeneity of
Externí odkaz:
https://doaj.org/article/246cb9f41dbf4f6e88edc22268ad7a97
Autor:
Eleonóra Klímová
Publikováno v:
Neurologie pro praxi. 21:3-10
Za posledne roky sme svedkami obrovskeho narastu možnosti liecby sclerosis multiplex (SM) liekmi s roznym mechanizmom ucinku, ktore ovplyvňuju imunitný system imunomodulaciou alebo imunosupresiou. S prichodom nových liekov s vyssou ucinnosťou, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c552a42f04b3656a08e5ec8560709921
https://doi.org/10.36290/neu.2021.007
https://doi.org/10.36290/neu.2021.007
Autor:
Zuzana Števková, Jozef Michalik, Jarmila Szilasiova, Miriam Fedičová, Georgi Krastev, Ľubica Snopeková, Viera Hančinová, Anna Cvengrošová, Andrea Cimprichová, Vladimir Donath, Slavomíra Kováčová, Eleonóra Klímová, Edita Kahancová, Ema Kantorová, František Jurčaga, Jakub Gazda, Ladislav Gurčík, Martin Karlík, Andrea Megová, Pavol Mikula
Publikováno v:
Neurological Research. 44:38-46
Objective : Neuromyelitis optica spectrum disorders (NMOSDs) are a group of rare, inflammatory, demyelinating diseases that affect the central nervous system. Neither the incidence nor the prevalence of NMOSD has been determined in Slovakia thus far.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::726bdc3d2f909bbef5ccccb424a8be26
https://doi.org/10.1080/01616412.2021.1952741
https://doi.org/10.1080/01616412.2021.1952741
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 18, Iss 8645, p 8645 (2021)
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health
Background: Multiple sclerosis (MS) is a chronic disease of the central nervous system that also develops in patients under 18 years of age. The disease negatively affects the quality of life (QoL) of children and adolescents. We conducted a literatu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ff9374a980a01c742d3de54aeca1fd9
https://www.mdpi.com/1660-4601/18/16/8645
https://www.mdpi.com/1660-4601/18/16/8645
Autor:
Tünde Csépány, Eleonóra Klímová, Peter Turcˇáni, Tanja Hojs Fabjan, Johann Sellner, Zsolt Illes, Pavel Štouracˇ, Fritz Leutmezer, Saša Šega Jazbec, Krzysztof Selmaj, Monika Adamczyk-Sowa, Marta Vachová, Franz Fazekas, Dana Horakova, Manuela Vaneckova, Alenka Horvat Ledinek, Csilla Rozsa, Thomas Berger, Gisela Kobelt, Konrad Rejdak, Eva Havrdova, Jarmila Szilasiova, László Vécsei
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 13 (2020)
Berger, T, Adamczyk-Sowa, M, Csépány, T, Fazekas, F, Fabjan, T H, Horáková, D, Ledinek, A H, Illes, Z, Kobelt, G, Jazbec, S Š, Klímová, E, Leutmezer, F, Rejdak, K, Rozsa, C, Sellner, J, Selmaj, K, Štouracˇ, P, Szilasiová, J, Turcˇáni, P, Vachová, M, Vanecková, M, Vécsei, L & Havrdová, E K 2020, ' Factors influencing daily treatment choices in multiple sclerosis : practice guidelines, biomarkers and burden of disease ', Therapeutic Advances in Neurological Disorders, vol. 13 . https://doi.org/10.1177/1756286420975223
Therapeutic Advances in Neurological Disorders
Berger, T, Adamczyk-Sowa, M, Csépány, T, Fazekas, F, Fabjan, T H, Horáková, D, Ledinek, A H, Illes, Z, Kobelt, G, Jazbec, S Š, Klímová, E, Leutmezer, F, Rejdak, K, Rozsa, C, Sellner, J, Selmaj, K, Štouracˇ, P, Szilasiová, J, Turcˇáni, P, Vachová, M, Vanecková, M, Vécsei, L & Havrdová, E K 2020, ' Factors influencing daily treatment choices in multiple sclerosis : practice guidelines, biomarkers and burden of disease ', Therapeutic Advances in Neurological Disorders, vol. 13 . https://doi.org/10.1177/1756286420975223
Therapeutic Advances in Neurological Disorders
At two meetings of a Central European board of multiple sclerosis (MS) experts in 2018 and 2019 factors influencing daily treatment choices in MS, especially practice guidelines, biomarkers and burden of disease, were discussed. The heterogeneity of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ae628693c3aad53f0b65b6293511a15
https://doaj.org/article/246cb9f41dbf4f6e88edc22268ad7a97
https://doaj.org/article/246cb9f41dbf4f6e88edc22268ad7a97
Publikováno v:
Česká a slovenská neurologie a neurochirurgie. :660-665
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::317b2285a35389b642fe67438eb4ea1f
https://doi.org/10.14735/amcsnn2017660
https://doi.org/10.14735/amcsnn2017660
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND The objective of this study was to evaluate the effect of a rehabilitation program in changing the perception of fatigue in patients with multiple sclerosis. MATERIAL AND METHODS The study involved 65 respondents/patients with clinically c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f13479a8a112f85bae14912e1b6ae7d9
https://pubmed.ncbi.nlm.nih.gov/30120829
https://pubmed.ncbi.nlm.nih.gov/30120829
Autor:
Marta Vachová, Peter Turcani, Zsolt Illes, Csilla Rozsa, Tünde Csépány, Monika Adamczyk-Sowa, Saša Šega Jazbec, Fritz Leutmezer, Franz Fazekas, Eleonóra Klímová, Dana Horakova, Tanja Hojs Fabjan, Eva Havrdova, Konrad Rejdak, Jarmila Szilasiova, Thomas Berger, László Vécsei
Publikováno v:
Therapeutic Advances in Neurological Disorders
Berger, T, Adamczyk-Sowa, M, Csépány, T, Fazekas, F, Hojs Fabjan, T, Horáková, D, Illes, Z, Klimová, E, Leutmezer, F, Rejdak, K, Rozsa, C, Šega Jazbec, S, Szilasiová, J, Turčáni, P, Vachová, M, Vécsei, L & Havrdová, E 2018, ' Management of multiple sclerosis patients in central European countries : current needs and potential solutions ', Therapeutic Advances in Neurological Disorders, vol. 11 . https://doi.org/10.1177/1756286418759189
Therapeutic Advances in Neurological Disorders, Vol 11 (2018)
Berger, T, Adamczyk-Sowa, M, Csépány, T, Fazekas, F, Hojs Fabjan, T, Horáková, D, Illes, Z, Klimová, E, Leutmezer, F, Rejdak, K, Rozsa, C, Šega Jazbec, S, Szilasiová, J, Turčáni, P, Vachová, M, Vécsei, L & Havrdová, E 2018, ' Management of multiple sclerosis patients in central European countries : current needs and potential solutions ', Therapeutic Advances in Neurological Disorders, vol. 11 . https://doi.org/10.1177/1756286418759189
Therapeutic Advances in Neurological Disorders, Vol 11 (2018)
Multiple sclerosis (MS) experts in Europe are facing rapidly rising demands of excellence due to the increasing complexity of MS therapy and management. A central European expert board of MS experts met to identify needs and obstacles with respect to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60123223e4307a1f23a4743c198663d3
Autor:
Jarmila, Szilasiová, Eleonóra, Klímová
Publikováno v:
Croatian medical journal. 45(3)
Susac syndrome is a rare microangiopathy of cochlea, retina, and brain. We report a case of a 30-year-old man with Susac syndrome. The patient initially suffered from unilateral hearing loss associated with peripheral vestibular syndrome, and followe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::db7f7efe9747803126d05bbfd2a37666
https://pubmed.ncbi.nlm.nih.gov/15185430
https://pubmed.ncbi.nlm.nih.gov/15185430